168 related articles for article (PubMed ID: 15064955)
1. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy.
Bandello F; Pognuz DR; Pirracchio A; Polito A
Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):1024-7. PubMed ID: 15064955
[TBL] [Abstract][Full Text] [Related]
2. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Bandello F; Polito A; Pognuz DR; Monaco P; Dimastrogiovanni A; Paissios J
Arch Ophthalmol; 2006 May; 124(5):643-50. PubMed ID: 16682585
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
4. Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N
Int Ophthalmol; 2004 Mar; 25(2):113-6. PubMed ID: 15290890
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
Zacks DN; Johnson MW
Retina; 2005; 25(2):135-40. PubMed ID: 15689801
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
Kytö JP; Angerman S; Lumiste E; Paloheimo M; Summanen PA
Acta Ophthalmol Scand; 2005 Oct; 83(5):605-8. PubMed ID: 16188001
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
9. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
10. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
Jonas JB; Kreissig I; Söfker A; Degenring RF
Arch Ophthalmol; 2003 Jan; 121(1):57-61. PubMed ID: 12523885
[TBL] [Abstract][Full Text] [Related]
13. Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.
Bressler NM; Edwards AR; Beck RW; Flaxel CJ; Glassman AR; Ip MS; Kollman C; Kuppermann BD; Stone TW;
Arch Ophthalmol; 2009 Dec; 127(12):1566-71. PubMed ID: 20008708
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Ho TC; Lai WW
Ophthalmologica; 2006; 220(5):349-50; author reply 350. PubMed ID: 16954717
[No Abstract] [Full Text] [Related]
16. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
17. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
18. Panretinal photocoagulation and intravitreal triamcinolone acetonide injection in four diabetic patients.
Er H
Retina; 2005; 25(5):675; author reply 675-6. PubMed ID: 16077375
[No Abstract] [Full Text] [Related]
19. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
20. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]